Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease

We have shown that Pravastatin, in an experimental model of early diabetes nephropathy preserves microvascular endothelial function in the presence of hyperglycemia, thus inhibiting the early stage of diabetic microangiopathy.